Develops a platform for measuring proteins and provides sample-analysis services to academic institutions, research laboratories, and biopharmaceutical companies.
10-K for FY2025, filed Feb 26, 2026The Nautilus VoyagerTM platform is designed to implement the Iterative Mapping method. The Nautilus Voyager platform integrates…View ↗
To bring the Nautilus Voyager platform to market, we are executing a phased commercialization strategy intended to balance scientific…View ↗
Building on the scientific and technical foundation established through our collaborations, we launched the Nautilus Iterative Mapping…View ↗
We intend to label and sell our products for research purposes only (“RUO”) and expect to sell them to academic institutions, life sciences…View ↗
No revenue reported yet.
10-K for FY2025, filed Feb 26, 2026
Academic institutions, research organizations, and biopharmaceutical companies engage with Nautilus through collaborations and Early Access services. Planned platform sales are direct in the United States and direct or through distributors elsewhere.
10-K for FY2025, filed Feb 26, 2026Collaborations and partnerships remain a foundational element of our go-to-market approach. We continue to work closely with select…View ↗
Building on the scientific and technical foundation established through our collaborations, we launched the Nautilus Iterative Mapping…View ↗
We intend to commercialize our Nautilus platform through a direct sales channel in the United States, and through both direct and…View ↗
Early-access services
Moved from planning an early-access phase to offering sample-analysis services for selected customers, beginning with a tau proteoform assay; broader platform commercialization remains a later step.
10-K for FY2022, filed Feb 23, 2023 10-K for FY2025, filed Feb 26, 2026We plan to initially target the life sciences proteomics research market and are currently entering the first phase of our product…View ↗
To bring the Nautilus Voyager platform to market, we are executing a phased commercialization strategy intended to balance scientific…View ↗
Building on the scientific and technical foundation established through our collaborations, we launched the Nautilus Iterative Mapping…View ↗
As we progress through the Early Access Program, we are preparing for broader commercial availability of the Nautilus Voyager platform and…View ↗
Competes with Thermo Fisher Scientific, Bruker, Agilent Technologies, Danaher, Becton, Dickinson, Quanterix, and Illumina
10-K for FY2025, filed Feb 26, 2026The life sciences market is highly competitive. There are other companies, both established and early-stage, that have indicated that they…View ↗
Loading...